Literature DB >> 19716339

Platelet utilization in the developing world: strategies to optimize platelet transfusion practices.

Anupam Verma1, Prashant Agarwal.   

Abstract

There is perennial shortage of blood and blood components in most of the developing world. The resources are inadequate in terms of meeting the ever growing demand of blood components especially platelets. A poor health care system has led to underdevelopment of blood transfusion services which ultimately affect the transfusion practices. There is a paucity of comprehensive data on the platelet usage from the developing countries which is reflective of their modest development in blood component therapy. This is in sharp contrast to the fast pace of development in platelet transfusion practice in developed world where platelet substitutes are to become a reality for clinical use in near future. In developing world a considerable heterogeneity exists for platelet transfusion practices between countries, and even within countries in hospitals where this precious resource is available. This variation in existing practices can partly be explained by factors like individual preferences, lack of any hospital transfusion policy with regard to platelet transfusion, problems of platelet availability, etc. There is a need to implement best platelet transfusion practices as platelet products are scarcely available and expensive. Few interventions are emphasized in this article in the context of improving the status of platelet utilization in developing countries.

Mesh:

Year:  2009        PMID: 19716339     DOI: 10.1016/j.transci.2009.07.005

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  20 in total

1.  Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.

Authors:  Lise J Estcourt; Callum Ingram; Carolyn Doree; Sally Hopewell; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02

2.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Gemma L Crighton; Erica M Wood; Simon Stanworth; Marialena Trivella; Carolyn Doree; Alan Tinmouth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2014

3.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Richard Gregg; Simon Stanworth; Carolyn Doree; Marialena Trivella; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

4.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

5.  Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

6.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Marialena Trivella; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

7.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.

Authors:  Michael Desborough; Lise J Estcourt; Anna Chaimani; Carolyn Doree; Sally Hopewell; Marialena Trivella; Andreas V Hadjinicolaou; Paresh Vyas; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-01-26

8.  Unfurling the rationale use of platelet transfusion in dengue Fever.

Authors:  P Pallavi; C K Ganesh; K Jayashree; G V Manjunath
Journal:  Indian J Hematol Blood Transfus       Date:  2011-04-11       Impact factor: 0.900

Review 9.  Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.

Authors:  Lise J Estcourt; Callum Ingram; Carolyn Doree; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-05-24

Review 10.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.